NASDAQ:CGEM | Profit Breakdown | Cullinan Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$57.25M-$53.7M
2026-03-31-$53.7M-$49.66M
2025-12-31-$55.26M-$50.71M
2025-09-30-$55.6M-$50.61M
2025-06-30-$75.8M-$70.06M
2025-03-31-$55M-$48.5M
2024-12-31-$55.05M-$47.65M
2024-09-30-$48.86M-$40.56M
2024-06-30-$50.03M-$42.03M
2024-03-31-$42.99M-$37.15M
2023-12-31-$45.49M-$39.69M-$23.8M
2023-09-30-$45.24M-$39.18M-$39.18M
2023-06-30-$37.61M-$32.21M-$32.21M
2023-03-31-$62.76M-$58.14M-$57.96M
2022-12-31$0.00-$32.61M-$28.95M-$26.78M
2022-09-30$0.00-$29.77M-$27.41M-$24.8M
2022-06-30$0.00$239.68M$240.14M$174.9M
2022-03-31$0.00-$32.66M-$32.46M-$12.1M
2021-12-31$0.00-$34.35M-$34.21M-$32.51M
2021-09-30$0.00-$18.38M-$18.26M-$17.35M
2021-06-30$0.00-$16.6M-$16.44M-$15.64M
2021-03-31$18.94M$1.37M$1.42M-$70,000.00
2020-12-31-$29.17M-$28.35M
2020-09-30-$11.5M-$9.86M
2020-06-30-$14.12M-$8.62M
2020-03-31-$5.54M-$4.97M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$241.65M-$219.88M-$219.88M
2024-12-31-$196.92M-$167.46M-$167.38M
2023-12-31-$191.09M-$169.22M-$153.16M
2022-12-31$0.00$144.65M$151.32M$111.21M
2021-12-31$18.94M-$67.95M-$67.49M-$65.57M
2020-12-31$0.00-$60.34M-$51.8M